Latvia vs Poland: HICP - Tea, mate and other plant-derived products for infusion (ND)
Latvia
1.88
in 2026
Poland
1.72
in 2026
Latvia rank
4th
Poland rank
5th
HICP - Tea, mate and other plant-derived products for infusion (ND) over time
- Latvia
- Poland
How they compare
Latvia currently reports 1.88 against 1.72 in Poland, a difference of 0.16.
That makes Latvia's figure about 1.1 times Poland's.
The two have swapped places 3 times across 31 shared years of data; in 1996 it was Poland ahead.
Latvia ranks 4th and Poland ranks 5th of 27 countries.
Across the 4 decades both report, Latvia averaged higher in 1 and Poland in 3.
Head to head by decade
| Decade | Latvia | Poland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 2.77 | 3.55 | 0.78 | Poland |
| 2000s | 2.28 | 2.62 | 0.341 | Poland |
| 2010s | 1.78 | 1.98 | 0.197 | Poland |
| 2020s | 2.31 | 1.44 | 0.8671 | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hicp - tea, mate and other plant-derived products for infusion (nd), Latvia or Poland?
- Latvia, at 1.88 against 1.72 in Poland as of 2026.
- What is the difference in hicp - tea, mate and other plant-derived products for infusion (nd) between Latvia and Poland?
- 0.16, with Latvia ahead.
- How many years of comparable data are there for Latvia and Poland?
- 31 years are reported by both, from 1996 to 2026.
- How do Latvia and Poland rank globally for hicp - tea, mate and other plant-derived products for infusion (nd)?
- Latvia ranks 4th and Poland ranks 5th of 27 countries.
- Where does this data come from?
- European Central Bank, published as HICP - Tea, mate and other plant-derived products for infusion (ND) (Neither seasonally nor working day adjusted, Sub-index weight). Statizoid refreshes it automatically from the source and publishes the full history for both places.